Now we're being told to talk about seratonin affect and how we can reduce antipsychotic dose with Nuedexta. POA in Philly was a course on how to sell off label and not get caught. Seratonin syndrome due to blocking CYP not Nuedexta's affect on SERT She is a fool. Hey Hey Hey I'm calling the FDA.
So what...this is Avanir, it's our culture. Push for 30% of all residents in LTC is a joke. Not all residents have AD, stroke, TBT etc = - 30% PRISM -30% scored 13 or higher. That indicates pba MAY be present and further evaluation is recommended to determine PBA diagnosis, NOT that they have PBA. We just need to keep getting lists of names, pull their charts and flag them. Then the MD I am paying bribes to can put them on drug and see what happens. Nothing to see here FDA, keep moving on. Money first... patients are old, going to die soon anyway.
that is how it has been done in NY and NJ for the last 3 years. Works like a charm. One more thing that works like a charm is selling compounding in those states as well